Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

On February 19, 2019, Posted by , In News, By ,, , With Comments Off on Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

The new Helmholtz Institute for Translational Oncology (HI-TRON Mainz) aims to develop into one of the world’s leading centres for personalised cancer immunotherapy. This is the ambitious goal of the cooperation partners German Cancer Research Center (DKFZ) and Research Institute for Translational Oncology (TRON gGmbH) at the Johannes Gutenberg University…

Opening of the first Fraunhofer Project Center in Israel

On February 19, 2019, Posted by , In News, By , , With Comments Off on Opening of the first Fraunhofer Project Center in Israel

Fraunhofer has been working successfully with research partners in Israel for almost ten years. This cooperation is now being further expanded. The first two Fraunhofer Project Centers at the Hebrew University of Jerusalem in Israel will be open in April Fraunhofer Project Center for Drug Discovery and Delivery – as…

Merck and BioMed X expand collaboration to immunology research

On February 15, 2019, Posted by , In News, By , , With Comments Off on Merck and BioMed X expand collaboration to immunology research

Heidelberg, Germany, February 14th, 2019 – BioMed X announced today to add a further research program to the collaboration with Merck. In accordance with the provisions of the existing contract, a new crowdsourcing project will be launched in the field of autoimmune diseases. BioMed X and Merck started their partnership…

Learning from the best part 2: Nurturing the BioRN regional startup ecosystem.

On February 5, 2019, Posted by , In Press Releases, By , With Comments Off on Learning from the best part 2: Nurturing the BioRN regional startup ecosystem.

Heidelberg, 01.02.2019 In its visionary mission, BioRN aims to develop the region into a world-leading life science cluster, by nurturing the regional startup ecosystem, attract global investments and talents. Within its new strategy, BioRN propose as potential instrument to enable this process the conception of an incubator in Heidelberg. A…

NEC provides a digital scanner to the Heidelberg University Hospital to accelerate joint research on cancer treatment

On January 28, 2019, Posted by , In News, By , , With Comments Off on NEC provides a digital scanner to the Heidelberg University Hospital to accelerate joint research on cancer treatment

NEC Laboratories Europe GmbH (NEC) provided a very high-resolution digital scanner to the Department of Applied Tumor Biology at the Institute of Pathology of the Heidelberg University Hospital for digitizing images of cancer tissue samples. The Heidelberg scientists Prof. Dr. Magnus of Knebel Doeberitz and Dr. Matthias Kloor with Motoo…

Learning from the best: how to accelerate academic research to the clinic.

On January 25, 2019, Posted by , In Press Releases, By , With Comments Off on Learning from the best: how to accelerate academic research to the clinic.

Heidelberg, 25.01.2019 Within its new strategy, BioRN led special attention on the improvement of the academic translational potential and in leveraging the unique combination of global pharma and leading innovators in the network. BioRN executive and strategic boards created a working group with a specific focus on accelerating academic research…

Miltenyi Biotec joins EMBL’s Corporate Partnership Programme

On January 18, 2019, Posted by , In News, By , , With Comments Off on Miltenyi Biotec joins EMBL’s Corporate Partnership Programme

Joining forces to advance training in biomedical research and therapy EMBL and Miltenyi Biotec, a global provider of products and services that advance biomedical research and cellular therapy from basic and translational research to clinical application, have teamed up in the EMBL Advanced Training Centre Corporate Partnership Programme to advance research…

BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

On January 18, 2019, Posted by , In News, By , , With Comments Off on BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

Heidelberg, Germany, January 17th, 2019 – BioMed X announced a new crowdsourcing project within its framework collaboration with Boehringer Ingelheim. BioMed X and Boehringer Ingelheim started their partnership in 2014 and since then have initiated three preclinical research projects in the fields of respiratory diseases, neuroscience and immunology. The new…

“Life Time” – European research for a healthier future

On January 15, 2019, Posted by , In News, By , , With Comments Off on “Life Time” – European research for a healthier future

Our body’s cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to discover. The consortium is jointly coordinated by the Max Delbrück Center in Berlin and…

Solmic Research GmbH and the European Molecular Biology Laboratory enter into a research collaboration

On December 3, 2018, Posted by , In News, By , With Comments Off on Solmic Research GmbH and the European Molecular Biology Laboratory enter into a research collaboration

Solmic Research GmbH has entered into a research collaboration with the European Molecular Biology Laboratory (EMBL) with the goal to elucidate the mode of action of natural extracts. Natural extracts, such as active ingredients of plants, are the origin of medicine and are widely used for medical applications, especially in…